29 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34467765 | Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties. | 2021 Sep 23 | 2 |
2 | 32250181 | Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery. | 2020 May | 1 |
3 | 32899016 | 5-HT3 blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study. | 2020 Sep 4 | 1 |
4 | 30797147 | Potential roles of 5-HT3 receptor (5-HT3R) antagonists in modulating the effects of nicotine. | 2019 Apr | 1 |
5 | 27816366 | Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial. | 2017 Mar | 1 |
6 | 26576669 | Potential serotonergic agents for the treatment of schizophrenia. | 2016 | 1 |
7 | 27677804 | Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT3 A receptor. | 2016 Dec | 1 |
8 | 26565961 | Galanin-Mediated Behavioural Hyperalgesia from the Dorsomedial Nucleus of the Hypothalamus Involves Two Independent Descending Pronociceptive Pathways. | 2015 | 1 |
9 | 22458709 | Differences in regional cerebral blood flow response to a 5HT3 antagonist in early- and late-onset cocaine-dependent subjects. | 2014 Mar | 1 |
10 | 23126479 | There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients. | 2013 Jun | 1 |
11 | 23321066 | Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes. | 2013 Apr | 2 |
12 | 23897038 | Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron. | 2013 Sep | 3 |
13 | 22644261 | Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study. | 2012 Sep | 1 |
14 | 23050164 | Assessment of ondansetron-associated hypokalemia in pediatric oncology patients. | 2012 | 1 |
15 | 18670328 | Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. | 2008 Aug 1 | 1 |
16 | 17562330 | Influence of immunomodulatory drugs on the cytotoxicity induced by monoclonal antibody 17-1A and interleukin-2. | 2007 Mar | 1 |
17 | 15554432 | Fatigue complicating chronic liver disease. | 2004 Dec | 1 |
18 | 11212100 | The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist. | 2001 Feb 12 | 1 |
19 | 11762972 | Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. | 2001 Nov | 1 |
20 | 10997728 | Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. | 2000 Sep | 1 |
21 | 8856622 | Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study. | 1996 Aug | 3 |
22 | 22298739 | The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man. | 1995 Jan | 1 |
23 | 8299095 | The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. | 1994 Feb 1 | 1 |
24 | 8347903 | Use of ondansetron for control of projectile vomiting in patients with neurosurgical trauma: two case reports. | 1993 May | 1 |
25 | 1838490 | [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology]. | 1991 | 1 |
26 | 1831542 | Evaluation of the 5HT3 antagonist ondansetron (O) for cocaine (C)-like activity and abuse potential. | 1990 | 1 |
27 | 2138064 | Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalan. | 1990 | 1 |
28 | 2144721 | 5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment. | 1990 Aug | 2 |
29 | 2525078 | The efficacy and safety of GR38032F in the prophylaxis of ifosfamide-induced nausea and vomiting. | 1989 | 1 |